Ching Lee Holdings (3728.HK) Reports Resilient Performance with Revenue Growth Amid Margin Pressure ACN Newswire

Ching Lee Holdings (3728.HK) Reports Resilient Performance with Revenue Growth Amid Margin Pressure

HONG KONG, Jun 29, 2026 - (ACN Newswire via SeaPRwire.com) - Ching Lee Holdings Limited (the “Group”, stock code: 3728.HK) announced its annual results for the twelve months ended 31 March 2026. Revenue increased by 14% year-on-year to approximately HK$1.47 billion.All operating segments recorded growth during the year. Revenue contributions included HK$1.4 million from substructure construction works, HK$1,407.6 million from superstructure construction works, HK$57.4 million from repair, maintenance, alteration and addition (“RMAA”) services, as well as HK$0.2 million from property leasing.Administrative and other operating expenses, together with finance costs, decreased by HK$10.1 million. Profit for the year amounted to HK$7.0 million. However, due to higher cost of revenue resulting in a lower operating profit margin in 2026, net profit decreased by 25.6% compared with the previous year.In response to heightened safety awareness within Hong Kong’s construction industry, the Group has increased its investment in safety resources to further enhance its safety standards. At the same time, the Group has adopted Building Information Modelling (BIM) technology to optimise construction processes, improve cost efficiency, and support overall business performance.The Group’s Chairman, Mr. Ng Choi Wah, commented, “We remain confident in Hong Kong’s economic outlook and the prospects of the construction sector. The anticipated recovery of the property market, together with the Northern Metropolis development plan, is expected to provide continued support to the growth of the local construction industry.”Media enquiries:New Smile Limited Strategic IR & PR Consultancy Tel: +852 2126 7076Jenny Lai jenny.lai@newsmilehk.comJC Ching jacey.ching@newsmilehk.comZelia Wong zelia.wong@newsmilehk.comNote to editors:Ching Lee Holdings Limited “Ching Lee” or “The Group”Ching Lee Holdings Limited, a limited liability company incorporated under the laws of the Cayman Islands, is a contractor in Hong Kong with over 28 years of experience in public and private sectors. The principal activities of Ching Lee Holdings and its subsidiaries are the provision of construction and consultancy works and project management services in Hong Kong, engaged in providing substructure building works services, superstructure building works services, and repair, maintenance, alteration and addition (RMAA) works services. Ching Lee Holdings Limited was transferred from GEM board to the main board in HKEx on September 18, 2017 with stock code 3728.hk. Company website: http://www.chingleeholdings.com Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Everest Medicines Announces NMPA Acceptance of the BLA for LEROCHOL(R), Offering a Potential New Treatment Option for Hypercholesterolemia in China ACN Newswire

Everest Medicines Announces NMPA Acceptance of the BLA for LEROCHOL(R), Offering a Potential New Treatment Option for Hypercholesterolemia in China

HONG KONG, Jun 26, 2026 - (ACN Newswire via SeaPRwire.com) - June 26, 2026, Everest Medicines today announced that China’s National Medical Products Administration (NMPA) accepted the Biologics License Application (BLA) for LEROCHOL(R) (lerodalcibep), a third-generation PCSK9 inhibitor, for subcutaneous use as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH). The on-schedule acceptance underscores the Company's disciplined execution of its clinical and regulatory strategy, and marks another key R&D milestone for 2026.LEROCHOL(R) is a novel, third-generation small recombinant fusion protein therapeutic agent comprised of a proprotein convertase subtilisin/kexin type 9 (PCSK9)-binding domain (Adnectin) and human serum albumin (HSA) with an approximate molecular weight of 77 kDa and binds PCSK9 with picomolar affinity. The recommended dosage of LEROCHOL(R) is 300 mg administered subcutaneously once monthly. LEROCHOL(R) may be kept at room temperature up to 25°C for up to 3 months prior to use. These features make LEROCHOL(R) a unique alternative to other PCSK9 inhibitors.It is worth noting that CVD remains the leading cause of death globally and in China. Extensive studies have confirmed that LDL-C is one of the most critical and modifiable risk factors for atherosclerotic cardiovascular disease (ASCVD). It has been identified as the primary intervention target for ASCVD prevention and treatment in both domestic and international lipid management guidelines. Despite the availability of existing lipid-lowering therapies, many patients with or at risk of CVD, including those with familial hypercholesterolemia (FH), still fail to achieve updated guideline-recommended LDL-C targets, highlighting the urgent need for more innovative treatment options. Despite an estimated 400 million individuals in China with dyslipidemia, only around 14% receive lipid-lowering treatment, reflecting low penetration and significant unmet medical need.“The NMPA’s acceptance of the BLA for LEROCHOL(R) brings renewed hope to patients,” said Professor Yong Huo, the leading principal investigator, Chief Cardiology Expert from Peking University First Hospital. “Results from the Phase 3 clinical trial demonstrated that Lerodalcibep significantly reduced LDL-C with a favorable safety and tolerability profile in Chinese patients with hypercholesterolemia. Its convenient monthly, single small-dose subcutaneous regimen, and up to 3-month room temperature stability address a significant unmet need in long-term lipid management for patients at home or during travel. We hope LEROCHOL(R) will soon be available to more patients.”“The BLA acceptance by the NMPA represents a significant step toward the commercialization of LEROCHOL(R) in Greater China,” said Mr. Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines. “As a potential best-in-class PCSK9 inhibitor, LEROCHOL(R) offers a novel treatment option with its robust lipid-lowering efficacy and favorable safety. It also provides extended room-temperature stability, enabling more convenient storage and travel, and supporting long-term lipid management at home. With the potential for approval in mainland China in 2027, we will continue to expand access to LEROCHOL(R) across Greater China, helping more patients benefit from this innovative therapy.”The application is based on results from multiple global clinical trials as well as Phase 3 clinical trial in China. In global clinical trials, LEROCHOL(R) demonstrated sustained LDL-C reductions of ≥60% in patients with, or at very-high or high risk of CVD and 59% in those with HeFH who have more severe LDL-C elevations. Results from the Phase 3 clinical trial of LEROCHOL(R) in China showed that LEROCHOL(R) significantly reduces LDL-C levels. Mean placebo adjusted LDL-C reductions from baseline in the co-primary end-points, were 65.9% at week 12 and 67.0% for the mean of weeks 10 and 12. Over 95% of participants on LEROCHOL(R) achieved dual Chinese lipid management guideline LDL-C targets.The U.S. Food and Drug Administration (FDA) has approved LEROCHOL(R), and it is currently under regulatory review by the European Medicines Agency (EMA).From the perspective of the Company’s overall strategic roadmap, the acceptance of the BLA for LEROCHOL(R) marks an important milestone in Everest Medicines’ continued efforts to deepen its strategic presence in the cardiovascular, kidney and metabolic (CKM) disease area. It will further enrich the Company’s innovative portfolio in the CKM field and provide a new growth driver for future commercialization. The timely acceptance of the BLA once again demonstrates the Company’s disciplined execution capabilities in advancing its established clinical and regulatory strategy. Looking ahead, Everest Medicines will continue to steadily advance the regulatory and commercialization process for LEROCHOL(R) in Greater China, with the goal of bringing this innovative treatment option to patients as early as possible and further strengthening the Company’s overall competitiveness in the CKM field. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
PT Merdeka Gold Resources Tbk Debuts on the Main Board of HKEX with a Secondary Listing ACN Newswire

PT Merdeka Gold Resources Tbk Debuts on the Main Board of HKEX with a Secondary Listing

HONG KONG, Jun 26, 2026 - (ACN Newswire via SeaPRwire.com) - PT Merdeka Gold Resources Tbk (“Merdeka Gold Resources”, “MGR” or the “Company”; IDX: EMAS), the owner and operator of the Pani Gold Mine and a majority-owned subsidiary of PT Merdeka Copper Gold Tbk (“MDKA” or the “Group”; IDX: MDKA), has completed its secondary listing on the Main Board of The Stock Exchange of Hong Kong Limited (“HKEX”) in the form of Hong Kong Depositary Receipts (“HDRs”) and officially commenced trading today under stock code 6228.MGR’s secondary listing on the Main Board of HKEX marks a historic milestone for the Company and represents a breakthrough for Indonesia’s capital markets on the global stage. Despite the prevailing macroeconomic uncertainties, the successful completion of this cross-border Public Offering underscores MGR’s robust business resilience and disciplined execution capabilities. By clearing the rigorous regulatory, corporate governance, and disclosure requirements of one of the world’s leading international financial centers, MGR has gained international validation that extends beyond typical emerging-market benchmarks. Meanwhile, this achievement reflects the confidence that sophisticated international investors have in high-quality Indonesian assets with solid fundamentals. As a landmark precedent, this listing is set to inspire more Indonesian enterprises with global ambitions, collectively enhancing Indonesia’s competitiveness and standing within the global financial ecosystem.The Hon Christopher HUI, GBS, JP, Secretary for Financial Services and the Treasury and Mr. Santoso KARTONO, President Commissioner of MGR (right).(From left to right)- Mr. Xinyu WANG, Commissioner of MGR- Mr. Suryadinata TANU, Director of MGR- Ms. Christina CHOI, Executive Director of the Securities and Futures Commission- Dr. Kelvin WONG, SBS, JP, Chairman of the Securities and Futures Commission- The Hon Christopher HUI, GBS, JP, Secretary for Financial Services and the Treasury- Dr. Jona Widhagdo PUTRI, Independent Commissioner of MGR- Mr. Santoso KARTONO, President Commissioner of MGR- Mr. Carlson TONG, Chairman of Hong Kong Exchanges and Clearing Limited- Mr. Julian LEE, Deputy Chairman of the HKEX Listing Committee- Ms. Bonnie Y CHAN, Chief Executive Officer of Hong Kong Exchanges and Clearing Limited- Mr. Boyke Poerbaya ABIDIN, President Director of MGR- Ms. Jessica WATTIMENA, Authorized Representative of MGR- Mr. John Mackay McCulloch WILLIAMSON, Independent Commissioner of MGR(From left to right)- Mr. Vincent LIU, CNGR Advanced Material Co., Ltd.- Mr. Xin ZHI, Provident Capital Partners- Mr. Liguo DING, Delong Iron and Steel Industry Group Co., Ltd.- Mr. Xuehua CHEN, Zhejiang Huayou Cobalt Co., Ltd.- Mr. Boyke Poerbaya ABIDIN, President Director of MGR- Mr. Santoso KARTONO, President Commissioner of MGR- Dr. Jona Widhagdo PUTRI, Independent Commissioner of MGR- Mr. John Mackay McCulloch WILLIAMSON, Independent Commissioner of MGR- Mr. Mingqing GAO, Wanguo Gold Group Limited- Ms. Jinzhu GAO, Wanguo Gold Group Limited- Mr. Shizhou YIN, JCHX Mining Management Co., Ltd.(From left to right)- The Hon Christopher HUI, GBS, JP, Secretary for Financial Services and the Treasury- Mr. Santoso KARTONO, President Commissioner of MGR- Ms. Christina CHOI, Executive Director, Corporate Finance of the Securities and Futures Commission (SFC)Mr. Santoso KARTONO, President Commissioner of MGR strikes the gong to mark the Company’s successful listing on the Main Board of HKEX.Dr. Jona Widhagdo PUTRI, Independent Commissioner of MGR delivers a speech.Mr. Boyke Poerbaya ABIDIN, President Director of MGR (right) presents a souvenir to HKEX.About PT Merdeka Gold Resources TbkPT Merdeka Gold Resources Tbk (IDX: EMAS) is an Indonesian gold mining company majority-owned by PT Merdeka Copper Gold Tbk (IDX: MDKA). The Company completed its listing on the Indonesia Stock Exchange in September 2025, as part of the Group’s efforts to optimize its capital structure and improve corporate transparency. MGR’s primary asset is the Pani Gold Mine in Gorontalo, Indonesia, one of the largest primary gold mines in Indonesia, with Mineral Resources of 7.0 million ounces of gold and an estimated mine life of approximately 15 years. Production is supported by a Heap Leach (“HL”) facility with an initial capacity of 8 million tonnes per annum. The Pani Gold Mine commenced initial mining activities in October 2025, achieved first gold production in February 2026, and completed its first gold sales in March 2026. The Company also plans to develop a Carbon-in-Leach (“CIL”) facility, targeting to commence operation in 2028 and scale up to a capacity of 22 million tonnes per annum by 2028, enabling peak production of approximately 545,000 ounces of gold per year by 2031. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

Tong Ren Tang Healthcare (02667.HK) Targets Hong Kong IPO

HONG KONG, Jun 26, 2026 - (ACN Newswire via SeaPRwire.com) - On June 26, 2026, Beijing Tong Ren Tang Healthcare Investment Co., Ltd. (“Tong Ren Tang Healthcare”) stands on the eve of its Hong Kong listing. Backed by the 357-year-old time-honored brand “Tong Ren Tang”, this TCM healthcare services provider today announced the launch of its Global Offering under the stock code 02667.HK. The Offer Price range is HK$5.48 to HK$6.21 per Share, representing a slight downward adjustment from the previous offering and a corresponding downward adjustment in the fundraising scale of approximately HK$226 million based on the maximum Offer Price, which demonstrates the Company’s more pragmatic pricing strategy in the current market environment. CICC acts as the sole sponsor, and dealings in its shares are expected to commence on July 7. The Global Offering comprises a total of 108,153,500 H Shares, of which 10% are under the Hong Kong Public Offering and 90% under the International Offering. Cornerstone investments account for approximately 46.79% of the offering.The Company launched an offering in March this year. Subsequently, it announced that, after comprehensively considering multiple objective factors including the then-current market environment and overall capital market conditions, and in order to fully protect the interests of investors and safeguard the long-term stable development of its brand, it had decided to postpone the Global Offering and its proposed listing on the Main Board of the Hong Kong Stock Exchange. With the offering now relaunched, the competitiveness of this time-honored brand in the TCM healthcare sector remains compelling. From brand barriers and earnings quality to full-industry-chain synergies and low-cost expansion, Tong Ren Tang Healthcare has accumulated advantages that form a solid foundation for its long-term development.The First Listed TCM Group: 0.16% Promotion Expense Ratio Far Below Peers, with 20.5% Annual Membership GrowthTong Ren Tang is one of China’s few national brands with a history of more than three centuries. As the only subsidiary of TRT Group strategically focused on TCM healthcare services, Tong Ren Tang Healthcare combines the essence of traditional Chinese medicine with modern healthcare management services. Through standardized chain operations and modernized management systems, it provides one-stop, customized TCM healthcare services.The power of the brand is most directly reflected in customer acquisition costs. According to its prospectus, in 2025, the Company's promotion expenses (included in selling and distribution expenses) were RMB1.844 million, representing a promotion expense ratio of just 0.16%, significantly lower than the industry average of 0.5% to 2.0%. While other companies spend heavily to acquire customers, Tong Ren Tang naturally attracts organic traffic. This brand premium is the result of centuries of accumulation and represents a barrier that is difficult for any competitor to replicate.In terms of market position, based on total out-patient and in-patient visits in 2025, Tong Ren Tang Healthcare ranked first in China’s non-public TCM hospital healthcare service industry, with a market share of 1.5%. The cumulative number of members grew from 530,691 in 2023 to 770,174 in 2025, representing a CAGR of 20.5%. In an extremely fragmented TCM healthcare services market, securing the leading position itself demonstrates the power of the Company’s brand heritage being fully realized.Pioneer in Tiered Healthcare: Total Patient Visits Jump 94% in Two Years, with Customer Return Rate as High as 86%The Company is one of the pioneers in deploying a tiered, online-offline integrated healthcare network. Benefiting from the synergies of this network, total patient visits grew by 94% in two years, from 1.78 million in 2023 to 3.45 million in 2025. Moreover, the Company demonstrates extremely high customer stickiness. For example, its SXT Hospital recorded a customer return rate as high as 86.0% in 2025, indicating exceptional brand loyalty and service recognition. The Company’s offline medical institutions are operating in an orderly manner, its service network continues to expand across core city clusters, and its Internet healthcare services are advancing steadily. Core businesses such as chronic disease management, post-operative rehabilitation and TCM wellness are highly recognized by the market.Reaching Replicable Growth: Stable Revenue around RMB1.17B and RMB120M in Operating Cash Flow Build Virtuous CycleFinancial data provides the most compelling evidence. For the years ended December 31, 2023, 2024 and 2025, the Company’s revenue remained stable at RMB1.153 billion, RMB1.175 billion and RMB1.171 billion, respectively. The Company's operating cash flow has remained in net inflow, reaching approximately RMB120 million in 2025, with a stable gross profit margin of 18.9%. As of December 31, 2025, cash and cash equivalents stood at approximately RMB287.7 million. These figures depict a company that has moved beyond the validation stage and entered a virtuous cycle of “growth and profitability.”Full-Industry-Chain Synergies: 13 Self-owned + 13 Managed Medical Institutions with a Proprietary Supply ChainTong Ren Tang Healthcare benefits from the industrial barriers built by TRT Group across the full TCM industry value chain. Its self-owned healthcare service network covers hospitals, out-patient healthcare centers, clinics and community healthcare institutions. When combined with Tong Ren Tang’s nationwide pharmacy and clinic network, the density of institutions and service capacity could expand exponentially. The Company has begun providing online healthcare services through its self-owned Internet hospital for Tong Ren Tang’s offline pharmacies and physicians, with nationwide coverage. In addition, leveraging the resources of the Group, the Company obtained the exclusive right in January 2024 to sell the Tong Ren Tang-branded Angong Niuhuang Pills series to retailers in Zhejiang province. This “pharmaceuticals–retail–healthcare” full-industry-chain synergy represents a formidable structural advantage that pure-play healthcare service providers can hardly match.Trillion-RMB Market Opportunity: TCM Service Market Reached RMB1.07 Trillion in 2025, to Reach RMB1.69 Trillion by 2030From an industry fundamentals perspective, the Frost & Sullivan report shows that the market size of China's TCM healthcare service industry reached RMB1,072.1 billion in 2025 and is projected to grow to RMB1,690.6 billion by 2030, at a CAGR of 9.5%. By total TCM healthcare service revenue in 2025, this market represents a significant portion of China's healthcare expenditure. Benefiting from both policy support and market demand, the TCM healthcare sector is regarded as one of the core tracks of the “silver economy.” Furthermore, the concentration of China's non-public TCM healthcare service industry is extremely low, with the top five players accounting for only 5.4% of the market share. This implies that Tong Ren Tang Healthcare, as a sector leader with brand advantages and scalable operations, naturally possesses a first-mover and market integration advantage.ConclusionWith population aging accelerating, with the number of people aged 60 and above exceeding 320 million, and national policies strongly supporting the integrated healthcare industry, the TCM-featured healthcare sector enjoys broad prospects and significant potential. Tong Ren Tang Healthcare possesses unique brand barriers, a mature business model and vast market demand. Its long-term fundamentals are solid, its growth logic is clear, and the ecosystem value created by its brand premium and Group-level industry-chain synergies has yet to be fully priced in. For this 357-year-old time-honored brand, listing is an important opportunity for development—not the final destination.Reprinted from Ejinsight. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
IP Go-Global Business Matching Session held in Guangzhou ACN Newswire

IP Go-Global Business Matching Session held in Guangzhou

HONG KONG, Jun 26, 2026 - (ACN Newswire via SeaPRwire.com) - The IP Go-Global Business Matching Session, jointly organised by the Intellectual Property Department of the Hong Kong Special Administrative Region (HKSAR) and the Guangdong Administration for Market Regulation (Guangdong Intellectual Property Administration), co-organised by the Hong Kong Trade Development Council (HKTDC) and the Intellectual Property Office of Guangzhou Development District, and supported by the Hong Kong Economic and Trade Office in Guangdong, was held today at Science City in Guangzhou.The event arranged some 50 one-to-one business matching meetings between Guangdong enterprises and Hong Kong IP service providers. It also featured a networking luncheon and a thematic seminar which attracted more than 150 industry participants. The event is aimed at helping Chinese Mainland enterprises expand into international markets by leveraging Hong Kong as their primary launchpad and enhancing Guangdong-Hong Kong collaboration in the intellectual property field and strengthening global competitiveness.In December 2025, the HKTDC and the HKSAR Government jointly organised the 15th Business of IP Asia Forum. A dedicated “IP Go-Global Business Matching Session” was hosted during that forum. Building on the success of last year’s forum, this event serves as one of the key initiatives under the Guangdong-Hong Kong cooperation framework, further reinforcing Hong Kong’s unique role as a “super connector” and “super value-adder” in overall national development.Peter Wong, HKTDC’s Regional Director of Southern China said: “Against the backdrop of the country’s proactive promotion of expansion and its emphasis on high-quality development under the 15th Five-Year Plan, enterprises in Guangdong are actively expanding into overseas markets, driving sustained demand for internationally oriented IP services—particularly in overseas IP protection and dispute resolution. Hong Kong’s legal and intellectual property system aligns with international standards, and with its well-established professional services sector, Hong Kong is positioned to provide value-added, comprehensive support to Mainland enterprises. This enables them to effectively protect their innovations, mitigate operational risks, enhance overall competitiveness, and achieve global expansion.”David Wong, Director of Intellectual Property of the HKSAR Government said: “In the latest World Competitiveness Yearbook 2026, Hong Kong's global competitiveness has risen to second globally. Hong Kong is equipped with the unique advantages of the ‘one country, two systems’ principle, a sound common law system, an international business environment and world-class professional services, and is an ideal platform for Mainland enterprises to expand into overseas markets."The event brought together government representatives, enterprises, and IP professionals from both Guangdong and Hong Kong. Among them was a delegation of around 20 representatives nominated by associations of IP practitioners, including the Asian Patent Attorneys Association Hong Kong Group (APAA), the Hong Kong Chinese Patent Attorneys Association (HKCPAA), the Hong Kong Institute of Patent Practitioners Ltd (HIPP), the Hong Kong Institute of Trade Mark Practitioners (HKITMP), and The Law Society of Hong Kong (Intellectual Property Committee). Their participation in the event highlights Hong Kong’s strengths in international legal and professional services, and consolidates its role as a strategic platform for Mainland enterprises seeking to expand globally.Facilitating some 50 one-to-one business matching sessions between Guangdong enterprises and Hong Kong IP professionals, the event focused on aligning with practical needs, promoting direct exchanges between Guangdong’s innovation & technology, cultural and creative enterprises, and Hong Kong’s IP service providers. The initiative serves a dual purpose: to better understand the key needs of Guangdong enterprises in their global expansion efforts, and to showcase Hong Kong’s diverse IP professional services. The business matching arrangements are designed to enhance collaboration outcomes by establishing a regular exchange and matching platform, strengthening cooperation between the two places in IP protection, utilisation and services, promoting regional innovation and industrial upgrading, and fostering long-term partnerships.In addition to the business matching sessions, the thematic seminar covered key issues related to global expansion, including IP risk management, cross-border dispute resolution, global patent portfolio strategies, and international development approaches. It also introduced Hong Kong’s favourable business environment and relevant support policies, providing forward-looking and practical insights to help enterprises achieve steady growth amid a complex and evolving global landscape.The HKTDC will continue to work closely with stakeholders to promote more cross-border exchange and cooperation platforms, facilitate complementary advantages between Hong Kong and the Mainland in professional services, further strengthen Hong Kong’s position as a regional IP trading centre, and support enterprises in seizing opportunities and expanding internationally.Photo download: https://bit.ly/3R3WisLThe IP Go-Global Business Matching Business Session arranged some 50 one-to-one business matching meetings between Guangdong enterprises and Hong Kong IP service providers.The IP Go-Global Business Matching Business Session featured a networking luncheon and a thematic seminar, with the seminar covering key issues encountered by enterprises in the process of global expansion. Media enquiriesHKTDC’s Communications & Public Affairs DepartmentKaty WongTel: (852) 2584 4524Email: katy.ky.wong@hktdc.org About HKTDCThe Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on @hktdc and LinkedIn Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

KEYTOP PARKING INC. Officially Lists on the Main Board of Hong Kong Stock Exchange

HONG KONG, Jun 26, 2026 - (ACN Newswire via SeaPRwire.com) - KEYTOP PARKING INC. (“Keytop” or the “Company”, Stock Code: 2272.HK) announces that its shares have commenced trading on the Main Board of Hong Kong Stock Exchange under the stock code “2272.HK”. Under the Global Offering, a total of 10,112,280 H Shares were offered, comprising 10.00% Hong Kong Public Offer Shares and 90.00% International Placing Shares. The final Offer Price was set at HK$39.55 per H Share, with each board lot consisting of 60 H Shares. The net proceeds raised from the Global Offering amounted to approximately HK$340 million.Shares of the Company were actively traded on the first day of listing, with an intraday high of HK$122.8 per Share, and intraday low of HK$110.1 per Share as of press time. As of press time, the intraday high reflected an increase of approximately 210.5% relative to the offer price of HK$39.55 per share. Total trading volume as of press time was approximately 1.56 million shares, representing an aggregate turnover of approximately HK$175 million.As a leading smart parking space operator in China, Keytop is dedicated to driving the digital transformation of urban parking sectors. Established in 2006, Keytop has built three core business segments: smart parking systems, smart parking management services, and parking facility and platform operations, forming a comprehensive service ecosystem covering the entire smart parking industrial chain. According to an industry report issued by CIC Consulting, Keytop ranks No.2 in China’s smart parking space operation industry measured by revenue in 2024. As at the end of 2025, Keytop has delivered integrated services to more than 30,000 parking lots nationwide. Drawing on decades of on-the-ground industry experience, proprietary R&D capabilities and refined operational expertise, Keytop caters to the upgrading demands of urban static traffic and continuously spearheads technological and operational innovation across the sector.Leveraging cutting-edge digital technologies including AIoT and cloud computing, Keytop facilitates the full-scale digital upgrading of urban traffic and parking scenarios nationwide. Its business footprint covers diversified parking venues such as large commercial complexes, office buildings, residential communities, public facilities, hotels, scenic spots, schools, hospitals and logistics parks. Keytop operates an integrated full-stack business model underpinned by the synergy of its three core divisions, creating a closed-loop commercial ecosystem featuring “technology monetisation, service fees and operational value-added income”. This diversified portfolio effectively mitigates industrial cyclical fluctuations and underpins stable and sustainable growth.With nearly two decades of deep cultivation in the smart parking industry, Keytop has consistently led technological iteration and delivered multiple industry-first innovations. Its landmark developments include pioneering LED parking space indicators and video-based ticketless payment systems, followed by the launch of Yongce Pro, the first smart parking operation system in the industry in 2023. Through AI technology, Keytop has reshaped the traditional parking industry and steered the sector’s transition from manual on-site management to fully automated AI-driven operations. As at the end of 2025, Keytop’s business has expanded to over 60 countries and regions worldwide, serving more than 300 million vehicles cumulatively. Based on 2024 revenue metrics, Keytop is the second-largest smart parking space operator in China with a market share of 3.3% and retains the top position in large-scale commercial deployment of AI technologies within the industry.Keytop’s clear business layout, steady profitability and promising growth prospects have garnered widespread recognition and backing from capital market institutions. The IPO was jointly sponsored by CICC Hong Kong Securities Limited and CMBC International Limited. Prior to the listing, Keytop secured strategic investments from renowned industrial capital and venture capital institutions including Tencent and Hongtai Zhiying Equity Investment Center. Dual recognition from top-tier investment banks and star investors fully validates the capital market’s high regard for Keytop’s consistent and robust profitability, industry-leading AI technological moat and long-term growth potential.For its future development roadmap, Keytop intends to allocate the net proceeds from the Global Offering to four core areas. First, scale up R&D investment in underlying core technologies such as AI image recognition and cloud-native parking platforms, recruit high-calibre R&D talents and further strengthen overall technical capabilities. Second, deepen the parking facility and platform operations business, drive intelligent upgrading of existing parking facilities and increase the operational scale. Third, extend marketing and service networks and further explore global expansion opportunities. Fourth, supplement working capital and cover general corporate expenses.The listing on the Hong Kong Stock Exchange marks a pivotal milestone and a brand-new starting point for Keytop. Supported by the international capital market, Keytop will continue to focus on the core track of AI smart parking, iteratively upgrade core algorithms and intelligent operation systems, and accelerate market penetration across domestic cities and global expansion. It will address urban parking pain points through digital and intelligent solutions, advance the high-quality development of urban traffic, and strive to become a world-leading integrated service provider of AI smart parking solutions. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
XJTLU Strengthens Presence in Indonesia, Offers Double Degrees and Global Career Pathways ACN Newswire

XJTLU Strengthens Presence in Indonesia, Offers Double Degrees and Global Career Pathways

JAKARTA, June 26, 2026 - (ACN Newswire via SeaPRwire.com) - Xi’an Jiaotong-Liverpool University (XJTLU), an international joint venture university established through a collaboration between Xi’an Jiaotong University (China) and the University of Liverpool (UK), continues to strengthen its position as a leading global higher education institution, particularly in the Indonesian market.From left: Dr Joseph Seet, Dr Foedjiawati, Professor Youmin Xi, Dr Pietro Borsano, Huajie Gui, and Ivonne AdyIndonesia has emerged as XJTLU’s largest international market, with approximately 700 Indonesian students currently enrolled. For the upcoming September intake, undergraduate applications from Indonesia have reached over 1,500, accounting for around 38% of total international applications.“Currently, XJTLU has faculty members from more than 60 different countries and regions around the world. Our students also come from nearly 100 different countries and regions, creating a campus environment where they are well accustomed to a diverse, multicultural atmosphere, ”said Professor Youmin Xi, Executive President of XJTLU, at a Media Discussion held at DoubleTree Hotel Kemayoran, Jakarta, on Wednesday, 24 June 2026.Professor Xi added, “Our educational model focuses on how we can help students grow with agile thinking and a strong sense of wisdom. They are encouraged to develop a wide range of skills and to collaborate in advancing knowledge. We also support them in cultivating wisdom—the ability to think deeply and act wisely—by integrating knowledge from both Western and Eastern perspectives.”Currently, XJTLU offers more than 100 degree programmes across disciplines, including science, engineering, business, finance, architecture, urban planning, languages, and culture. All programmes are delivered in English, except for general and foundational courses. Undergraduate students graduate with two degrees: an XJTLU degree recognised by China’s Ministry of Education and a globally recognised degree from the University of Liverpool. Postgraduate students are awarded degrees from the University of Liverpool, which is also recognised by the Ministry of Education. All academic departments at XJTLU also offer PhD programmes, supporting the University’s vision to become a research-led international university in China with a distinctive global reputation.Meanwhile, an alumni representative, Tuty Julfa shared her experience studying at XJTLU, saying, “I feel very fortunate to have studied at XJTLU, primarily because it not only strengthened my hard skills but also developed the soft skills essential for my career growth. It’s not just about academics, but also about interpersonal skills and how we cultivate perseverance and resilience. These may seem like simple things, but they play a crucial role in shaping who I am today,” explained Tuty, who is now running a business in the fashion retail sector.As part of its international expansion strategy, XJTLU established its official representative office in Indonesia in 2024. This presence has played a key role in strengthening relationships with prospective students, academic partners, and other stakeholders. In June this year, XJTLU further expanded its recruitment team in Indonesia to enhance services and outreach.XJTLU has also built partnerships with leading educational institutions in Indonesia, including Binus University, Universitas Indonesia, Institut Teknologi Bandung, and Petra Christian University Surabaya. In addition, collaborations extend to education agencies as well as local and international schools.With strong growth momentum in Indonesia, XJTLU continues to reinforce its role as a global gateway for young talents seeking world-class education and international career opportunities.“This year marks the 20th anniversary of our university. The future world requires new pillars—individuals who are able to work alongside AI. From the first year, our students are introduced to what AI is, how to use it, and the ethics surrounding it. In the second year, they begin learning how to apply AI appropriately in subjects such as Mathematics, Engineering, and the Social Sciences. By the third year, they are supported by AI in conducting research to deepen their understanding. We use AI to support education—upgrading, restructuring, and reshaping it. However, we do not aim to use AI to replace education. As long as humanity exists, education will endure. Our philosophy is ‘X plus AI,’ not ‘AI plus X.’ AI is not only about learning, but also about building resilience for the future,” Professor Xi concluded.About Xi’an Jiaotong-Liverpool University (XJTLU)Xi’an Jiaotong-Liverpool University (XJTLU) is an international joint venture university founded by Xi’an Jiaotong University in China and the University of Liverpool in the United Kingdom. It combines the strengths of both prestigious parent institutions and is the largest of its kind approved by China’s Ministry of Education.Located in Suzhou, China, XJTLU offers a beautiful campus environment that blends rich cultural heritage with rapid economic development. Suzhou is one of China’s most advanced cities. XJTLU’s strategic location in the Suzhou Dushu Lake Science and Education Innovation District, within the Suzhou Industrial Park (SIP), provides exceptional access to business networks and industry collaboration opportunities.For more information about XJTLU, please visit: https://www.xjtlu.edu.cn/enFor media inquiries, please contactVionna Fiducia ThejaInternational Media and Communication TeamXi'an Jiaotong-Liverpool UniversityEmail: vionna.theja@xjtlu.edu.cnRahma AnanditaPR & Media ConsultantThe Union CommunicationsTel: 0815 8593 5835Email: dita@theunion.co.id Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

GIC Discloses Third Change in Shareholding in Ascletis Pharma Inc. -B (01672.HK) This Year: Further Increases Stake by Over 10 Million Shares, Raising Holding from 7.00% to 8.36%

HONG KONG, Jun 26, 2026 - (ACN Newswire via SeaPRwire.com) - Recently, Singapore’s sovereign wealth fund GIC updated its shareholding data for Ascletis Pharma Inc. -B (01672.HK) once again, marking its third Disclosure of Interests filing in the company this year. According to the filing, compared with the previous DI-registered shareholding of 74,808,000 shares, GIC newly acquired an additional 14,545,000 shares. Following the increase, its shareholding rose from 7.00% to 8.36%, representing another large-scale purchase exceeding 10 million shares.Looking back at the three DI disclosure milestones this year, GIC first crossed the 5% disclosure threshold in February, with its updated DI shareholding reaching 6.42%. After continued accumulation, its second disclosure in May showed that its stake had increased to 7.00%. The latest filing marks GIC’s third disclosure update this year, with the institution continuing to make substantial additions to its position. Its total shareholding has further risen to 89,353,000 shares, representing 8.36% of the company.As one of the world’s leading sovereign wealth funds, GIC has long adhered to a long-term value investment philosophy. Its three shareholding updates within the year and steady continued accumulation fully demonstrate the institution’s sustained confidence in Ascletis Pharma’s innovative drug pipeline, clinical development progress, and long-term growth potential. Continued investment by international long-only capital also provides a strong vote of confidence in the company’s development.At present, Ascletis Pharma is steadily advancing multiple core R&D pipelines. With further clinical data expected to be released going forward, and supported by continued investment from GIC and other overseas long-term institutional investors, the company is expected to remain a key focus of global capital markets. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
GA-ASI Adapts Ground Control Station to Fly MQ-9B ACN Newswire

GA-ASI Adapts Ground Control Station to Fly MQ-9B

SAN DIEGO, June 25, 2026 - (ACN Newswire via SeaPRwire.com) - General Atomics Aeronautical Systems, Inc. (GA-ASI) is working to adapt its Block 30 Ground Control Stations (GCS) to fly the company's newer model MQ-9B SkyGuardian® and SeaGuardian® Remotely Piloted Aircraft. When these upgrades are complete, they will enable current users of the Block 30 system, originally designed to fly the MQ-9A Reaper®, to keep that equipment and use it to operate the more capable aircraft.Current users include the U.S. Air Force, U.S. Marine Corps, the Italian Air Force, the French Air Force, the United Arab Emirates Armed Forces, the Spanish Air Force, and the Royal Netherlands Air Force.GA-ASI developed the MQ-9B through its own internal research and development. The upgraded new aircraft required a new and more powerful GCS. The ongoing work with the Block 30 GCS now means that prospective users with existing stocks of equipment wouldn't need to buy new ground control equipment to operate the MQ-9B aircraft they acquired."We want to do all we can to deliver to most capable model of our aircraft to our customers, and that's MQ-9B," said GA-ASI President David R. Alexander. "We also know that by investing our own Internal Research & Development dollars, we can deliver MQ-9B at a lower acquisition cost by adapting the GCS for our current customers."Company efforts to upgrade the Block 30 focus on its datalink capability for MQ-9B operation. This includes the installation of a new datalink rack, the GA Interface Multiplexor Encryptor, which is the heart of the MQ-9B communications and telemetry system. In addition to the hardware modifications, the software will also be tailored to interface with the unique capabilities on the MQ-9B.Once the modifications are made to Block 30, the GCS will be able to fly both the MQ-9A and the MQ-9B aircraft and will be easily switchable from one to the other.GA-ASI expects to begin flight testing the expanded Block 30 by the end of this year.About GA-ASIGeneral Atomics Aeronautical Systems, Inc., is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 9 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.GA-ASI Media RelationsGeneral Atomics Aeronautical Systems, Inc.ASI-MediaRelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Pacific Avenue Capital Partners Announces Investment Committee Appointment, New AI Initiative, and Team Expansion ACN Newswire

Pacific Avenue Capital Partners Announces Investment Committee Appointment, New AI Initiative, and Team Expansion

LOS ANGELES, CA, June 25, 2026 - (ACN Newswire via SeaPRwire.com) - Pacific Avenue Capital Partners ("Pacific Avenue"), a global private equity firm focused on corporate carve-outs and other complex transactions in the middle market, today announced the appointments of Jonathan Sinnott to the Investment Committee, the establishment of a dedicated artificial intelligence team led by Al Rahrooh and supported by Ahsan Hashmi and Alejandro Urrea, and the addition of Tyler Woodhouse, Adolfo Guerra, and Francisco Lima across portfolio operations and compliance, along with a new investment team member, Saiesha Sharma, as an associate."We remain committed to building the best private equity firm to work at in Los Angeles. Jonathan's appointment to the Investment Committee is a well-deserved recognition of his contributions and I look forward to his continued impact in this expanded role. Additionally, the establishment of our dedicated AI team is a critical initiative for the firm, and one we believe will create a meaningful competitive advantage for both Pacific Avenue and our portfolio companies. I am also thrilled to welcome Al, Tyler, Adolfo, Francisco, and our newest investment associate to the team, each of whom brings exceptional experience that will strengthen our ability to execute and create value across our portfolio."-Chris Sznewajs, Founder and Managing Partner of Pacific Avenue Capital PartnersPacific Avenue is pleased to announce the appointment of Jonathan Sinnott to the Investment Committee. Mr. Sinnott joined Pacific Avenue in 2018 and has since been promoted to Managing Director. During his tenure at Pacific Avenue, Mr. Sinnott has focused his efforts on transaction sourcing, execution, due diligence, and portfolio operations. His appointment to the Investment Committee reflects both his past contributions to the firm and his growing leadership role across the platform. Prior to joining Pacific Avenue, Mr. Sinnott was part of the Special Situations group of Oaktree Capital Management and the Financial Sponsors group at Credit Suisse. Mr. Sinnott received his M.B.A. from the UCLA Anderson School of Management and graduated with a B.A. from the University of Pennsylvania.The establishment of a dedicated artificial intelligence team has been a key initiative for the firm and will play an integral part in Pacific Avenue's strategy for driving value creation across our investment platform. The team is led by Al Rahrooh, Principal and Head of Artificial Intelligence. Prior to Pacific, Mr. Rahrooh served as Chief Technology Officer across multiple venture-backed organizations and co-founded LeNgineer, an R&D company that secured NASA SBIR funding to develop AI solutions for the Space Launch System. Mr. Rahrooh graduated with a B.S. in Biomedical Sciences from the University of Central Florida and is currently a Ph.D. candidate in Medical Informatics at UCLA. He is joined by two Associate Software Engineers, Ahsan Hashmi and Alejandro Urrea.Ahsan Hashmi joins the firm as an Associate Software Engineer. Prior to joining Pacific, Mr. Hashmi worked at NASA and across multiple organizations focused on data engineering and cloud-based AI solutions. Mr. Hashmi graduated with a B.S. from the University of Central Florida and holds an M.S. in Informatics from the University at Buffalo.Alejandro Urrea joins the firm as an Associate Software Engineer. Prior to joining Pacific, Mr. Urrea led AI and software engineering engagements across multiple organizations, designing and deploying production-grade AI systems. Mr. Urrea graduated with a B.S. in Computer Science from the University of Central Florida.The team is focused on two fronts: advancing the firm's own internal investment and operational processes and deploying AI-driven solutions directly within Pacific Avenue's portfolio companies. Pacific Avenue believes this initiative represents a significant opportunity to enhance value across its portfolio.Pacific Avenue further expanded its team with the addition of new professionals across portfolio operations and compliance. Tyler Woodhouse joins the firm as Principal of Portfolio Operations. Prior to joining Pacific, Mr. Woodhouse was a Director on the Portfolio Operations team at Atlas Holdings and previously served on Alvarez & Marsal's Private Equity Services team. Mr. Woodhouse earned an MBA from the Massachusetts Institute of Technology and a Bachelor of Science from the United States Military Academy at West Point.Adolfo Guerra joins the firm as Vice President of Portfolio Operations. Prior to joining Pacific, Mr. Guerra was an Engagement Manager at L.E.K. Consulting. Mr. Guerra graduated with a degree in Industrial Engineering from UFMG in Brazil and holds an MBA from INSEAD.Francisco Lima joins the firm as Compliance Manager. Prior to joining Pacific, Mr. Lima served as a Compliance Associate at Clearlake Capital Group, L.P. Mr. Lima graduated with a B.S. in Management and Business Economics with a minor in Political Science from the University of California, Merced.Finally, Pacific Avenue welcomed Saiesha Sharma to the Investment Team as an Associate. Prior to joining Pacific, Ms. Sharma was a Private Equity Analyst at CC Industries. Ms. Sharma graduated with a B.S. in Finance and a minor in Computer Science from Indiana University.About Pacific Avenue Capital PartnersPacific Avenue Capital Partners is a global private equity firm, headquartered in Los Angeles with an office in Paris, France. The firm is focused on corporate divestitures and other complex situations in the middle market. Pacific Avenue has extensive M&A and operations experience, allowing the firm to navigate complex transactions and unlock value through operational improvement, capital investment, and accelerated growth. Pacific Avenue takes a collaborative approach in partnering with strong management teams to drive lasting and strategic change while assisting businesses in reaching their full potential. Pacific Avenue has more than $3.9 billion of Assets Under Management (AUM) as of March 31, 2026. The members of the Pacific Avenue team have closed over 120 transactions, including over 50 corporate divestitures, across a multitude of industries throughout their combined careers. For more information, please visit www.pacificavenuecapital.com.PACP Ops Mgmt Co, LLC ("PACP Ops") is a Pacific Avenue-exclusive consulting firm that is wholly-owned by Pacific Avenue Capital Partners, LLC and affiliated with Pacific Avenue Capital Partners Management Company LLC. PACP Ops assists Pacific Avenue in areas of due diligence and in portfolio company operations and other initiatives. PACP Ops (and indirectly its employees) receives fees from Pacific Avenue portfolio companies, which do not reduce or otherwise offset the management fee paid by funds managed by Pacific Avenue. Employees joining PACP Ops include Al Rahrooh, Alejandro Urrea, Ahsan Hashmi, Tyler Woodhouse, and Adolfo Guerra.Chris BaddonManaging Directorcbaddon@pacificavenuecapital.comSOURCE: Pacific Avenue Capital Partners Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
10 winners selected at 9th edition of Start-up Express ACN Newswire

10 winners selected at 9th edition of Start-up Express

HONG KONG, Jun 25, 2026 - (ACN Newswire via SeaPRwire.com) - The ninth edition of Start-up Express, organised by the Hong Kong Trade Development Council (HKTDC), successfully concluded its Final Pitching Day today, with 10 winning start-ups emerging from the competition. The winning start-ups span sectors including smart city solutions, green tech and health tech, reflecting growing momentum among Hong Kong start-ups in translating innovative technologies into practical applications. The ESG Award was presented to BioZein Technology Corporation Limited in recognition of its outstanding commitment to sustainability and social impact, while Homing Therapeutics Limited received the My Favourite Start-up Award. The 10 winning start-ups will next participate in a series of local and overseas business events organised by the HKTDC which provides opportunities to build capability and connections, explore markets, seek business and funding partners, and enhance brand awareness.The HKTDC has long been committed to fostering the growth of start-ups by actively providing platforms that help them raise market visibility and expand into Chinese Mainland and international markets, to further promote Hong Kong’s strengths as an international innovation and technology hub. HKTDC Assistant Executive Director Anna Cheung said: “When we launched Start-up Express in 2018, we had one simple goal: to help Hong Kong start-ups grow and flourish. Since then, we have supported 80 start-ups in building capacity, enhancing their visibility, making connections, finding new partners and investors and seizing opportunities and markets previously out of their reach. We champion Hong Kong’s brightest startups by connecting them to the world to scale and succeed. Proudly, we stand with our winners every step of the way, unlocking partnerships, investment, and the power to build a global brand.”Ten winning start-ups were selected, with the majority operating in the fields of smart city solutions, alongside a number of ventures specialising in green tech, health tech and med tech, highlighting the increasing diversity of innovation and technology solutions and their growing adoption across a wide range of industries and everyday applications. This year’s Start-up Express Final Pitching Day attracted more than 200 industry participants, including investors and business leaders. Booths were also set up during the event to enable the Start-up Express finalists to showcase their businesses to all attendees and participants, fostering networking and collaboration opportunities.The 20 Start-up Express finalists took to the stage today to present their innovative business ideas and answer questions raised by the judging panel. Following the selection process, the 10 start-ups were announced as winners: Alpha AI Technology Limited, BioZein Technology Corporation Limited, GABES Limited, Hay-koze Limited, Homing Therapeutics Limited, Muuse Limited, O-Spheres Limited, PetWell HK Limited, PregnaSense Co. Limited and Pyramid AI Limited. The HKTDC will arrange a series of exposure opportunities for the winning teams to interact with potential investors, buyers and partners, helping them expand their business networks and capture opportunities in both local and global markets.Judges commend start-ups for embracing emerging technology trendsOne of the judges, Jimmy Tao, Chairman of the Hong Kong Startup Council, said: “The quality of participating start-ups continues to improve year after year. Many of this year’s finalists have successfully integrated artificial intelligence and other innovative technologies into practical applications, demonstrating strong commercial potential. Hong Kong’s start-up ecosystem has continued to flourish in recent years, with the number of start-ups reaching a record high. Last year, the total increased 11% year-on-year to 5,221, reflecting the city’s growing appeal to global entrepreneurs and reinforcing its position as an ideal destination for business and investment. Through the Start-up Express platform, this year’s winners will be well placed to expand into new markets while gaining valuable opportunities to build networks and accelerate growth.”Start-up Express helps start-ups expand markets and commercialise innovationTaranjit Singh, Chief Technology Officer of Entoptica, one of the 10 winning start-ups of Start-up Express 2025 and the world’s first start-up to apply quantum technology to vision science, said: “Start-up Express provided valuable opportunities to connect with investors and industry mentors, helping us secure funding to advance clinical trials and expand production capacity. Participation in HKTDC events has also enabled us to broaden our network within the ophthalmic healthcare sector.” He added that participation in CES 2026 in the United States in January this year, a participation led by the HKTDC, enabled the company to establish connections with potential partners, manufacturers and investors from Shanghai, Japan and the United States. The company also successfully sold two prototype products at US$100,000 each, achieving pricing and overall results that exceeded its expectations.Start-up Express International supports overseas start-ups to establish a presence in Hong KongIn addition to promoting local innovation and technology ventures, the HKTDC is committed to strengthening exchanges between Hong Kong and overseas start-up ecosystems, further reinforcing Hong Kong’s competitive edge as a leading innovation and technology hub in Asia. Since the launch of Start-up Express International in 2022, the competition has attracted start-ups from around the world over four editions, including participants from Chinese Mainland, Australia, France, Germany, the United Kingdom, Italy, Singapore, Thailand, Vietnam, the United Arab Emirates and the United States. The fifth edition of Start-up Express International will be held during Entrepreneur Day in December this year, providing winning overseas start-ups with support to establish a presence in Hong Kong and leverage the city as a gateway to explore opportunities in the Guangdong-Hong Kong-Macao Greater Bay Area and international markets.Start-up Express: https://portal.hktdc.com/startupexpress/en/The 20 finalists: https://portal.hktdc.com/startupexpress/en/s/Top-20Photo download: https://bit.ly/4wu3EFdThe 10 winners of Start-up Express. Representatives of the winning teams took a group photo with judges and guests. Back row (from third left), from left to right: Monica Hong, Associate of Betatron Venture Group; Alan Cheung, Founder & Managing Director of Grandion Group; HKTDC Assistant Executive Director Anna Cheung; Jimmy Tao, Chairman of Hong Kong Startup Council; Winnie Leung, Founding General Partner of Transcend Capital Partners and Conrad Tsang, Founder and Chairman of Strategic Year Holdings LimitedThe Start-up Express Final Pitching Day featured a student innovation showcase, where primary and secondary school students presented their award-winning innovation and technology projectsMore than 200 industry professionals attended the Start-up Express Final Pitching Day, providing opportunities for start-ups to exchange ideas and connect with investors and business leadersBooths alongside the event, where shortlisted start-ups introduced their businesses and innovative solutions to participants HKTDC Media Room: https://mediaroom.hktdc.com/enMedia enquiriesHKTDC’s Communications & Public Affairs DepartmentNoah QiuTel: (852) 2584 4575Email: noah.yl.qiu@hktdc.orgJohnny TsuiTel: (852) 2584 4395Email: johnny.cy.tsui@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
AEON Credit Records a Solid Start to FY2026/27 as First Quarter Net Profit Jumps 24.4% ACN Newswire

AEON Credit Records a Solid Start to FY2026/27 as First Quarter Net Profit Jumps 24.4%

HONG KONG, Jun 25, 2026 - (ACN Newswire via SeaPRwire.com) - AEON Credit Service (Asia) Company Limited (“AEON Credit” or the “Group”; Stock Code: 00900) today announced its results for the three months ended 31st May 2026 (“1QFY2026/27” or the “Reporting Period”).During the Reporting Period, the Group’s revenue increased 7.7% to HK$476.2 million, compared with HK$442.2 million in the first quarter of the previous year (“1QFY2025/26” or the “Previous Period”). Interest income rose 9.1% to HK$407.0 million, while interest expenses decreased 12.8% to HK$27.0 million as the average funding cost improved to 3.2% from 3.8% in the Previous Period, reflecting the Group’s effective funding strategy and diversified borrowing portfolio. Net interest income grew 11.1% to HK$380.0 million.Operating profit before impairment losses and impairment allowances rose 11.4% to HK$255.9 million, with the operating expense-to-operating income ratio improving to 43.3% from 44.6% in the Previous Period. Achieving an improvement in impairment losses and allowances of HK$4.6 million to HK$99.6 million in the Reporting Period, the Group’s profit after tax increased by 24.4% to HK$136.0 million (1QFY2025/26: HK$109.3 million), with earnings per share increasing to 32.47 HK cents for the Reporting Period (1QFY2025/26: 26.11 HK cents).Amidst an improving yet still challenging market environment, the Group refined its credit assessment scoring mechanism and made timely adjustments to credit exposure across selected business segments, enabling more granular risk differentiation and enhanced risk detection to strengthen the overall soundness of its credit portfolio. To address the needs of specific consumer groups, the Group also pursued product innovation, including the launch of renovation loans and personal loans for property owners in May 2026, further diversifying its customer base and reinforcing its competitive position in the personal loan market. Supported by targeted marketing initiatives focusing on overseas travel and domestic consumption, together with effective telemarketing and credit card promotional campaigns, the Group’s overall sales recorded steady growth of approximately 12.9% over the Previous Period. The gross advances and receivables balance remained at a similar level as at 28th February 2026, while asset quality continued to improve, with the percentage of doubtful (stage 2) and loss (stage 3) receivables to gross advances and receivables decreasing to 3.7% as at 31st May 2026 from 3.9% as at 28th February 2026.Looking ahead, the Group’s strategic focus for the remainder of 2026 will be on accelerating digital transformation and deepening ecosystem synergies to drive sustainable growth. A key driver will be the integration of artificial intelligence (AI) and advanced data analytics across all business functions to enhance customer experience, data-driven credit assessment, risk management and compliance. The Group aims to reduce electronic Know-Your-Customer (eKYC) processing times and streamline application and approval processes to deliver a smoother and more personalised customer journey, while embedding digital communication tools such as WhatsApp across various customer interfaces to improve engagement effectiveness and efficiency.The full implementation of a unified bonus point program is a central pillar of the Group’s growth plan. By integrating the loyalty rewards of participating merchant partners under a common platform, the Group aims to deepen customer engagement and enhance cross-selling opportunities across its business segments. AEON Stores (Hong Kong) Co., Limited is expected to become the first merchant partner to join the program, further strengthening the overall value proposition of the AEON Ecosystem and creating a more seamless and self-reinforcing “AEON EcoZone” for customers.The Group remains committed to incorporating sustainability into its decision-making, risk management and day-to-day business practices. This is recognized in the recent “Best Sustainability-Linked Loan – Non-Bank Financial Institution in Hong Kong” award received at “The Asset Triple A Sustainable Finance Awards 2026” for its HK$300 million syndicated sustainability-linked loan, as well as its inclusion in the S&P Global Sustainability Yearbook (China Edition) 2026, reflecting the Group’s capabilities in green finance and sustainable development.Mr. Wei Aiguo, Managing Director of AEON Credit, said, “We are pleased to deliver another quarter of strong profit growth, underpinned by improving operating efficiency, a lower funding cost and disciplined credit risk management. Moving forward in a dynamic macroeconomic environment, we will be focused on accelerating our digital transformation and deepening the synergies within the AEON Ecosystem. With our strong liquidity, robust balance sheet and proven management capabilities, we are confident in maintaining our growth trajectory and delivering long-term value to our stakeholders.”About AEON Credit Service (Asia) Company Limited (Stock Code: 00900)AEON Credit Service (Asia) Company Limited, a subsidiary of AEON Financial Service Co., Ltd. (TSE: 8570) and a member of the AEON Group, was set up in 1987, registered as a Hong Kong limited company in 1990, and listed on the Main Board of The Stock Exchange of Hong Kong Limited in 1995. The Group is principally engaged in the finance business, which includes credit card issuance, personal loan financing, card payment processing services and insurance intermediary business in Hong Kong, and microfinance business in the Chinese Mainland.For more information, please visit the company’s website at www.aeon.com.hk. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Global AI Boom Drives Strong Growth in Hong Kong’s May Exports ACN Newswire

Global AI Boom Drives Strong Growth in Hong Kong’s May Exports

HONG KONG, Jun 25, 2026 - (ACN Newswire via SeaPRwire.com) - Hong Kong’s merchandise exports rose by 40.8% year-on-year to HK$611.2 billion in May, according to data released today by the Census and Statistics Department. For the first five months of 2026, total exports of goods reached HK$2,776.6 billion, representing robust growth of 36.2% compared with the same period last year.“Hong Kong’s export performance continues to be underpinned by robust electronics demand, fueled by the ongoing surge in artificial intelligence (AI) adoption worldwide,” said Bruce Pang, Director of Research at the Hong Kong Trade Development Council.Market sentiment improved somewhat following the Xi-Trump meeting in Beijing in mid-May, though concerns over the Middle East conflict lingered. Looking ahead, the tentative easing of tensions after the US–Iran MoU signed in mid-June - despite potential volatility - together with softer oil prices, is expected to positively impact business prospects.“Overall, Hong Kong’s trade outlook will continue to hinge on several factors, including the technology upcycle, geopolitical developments, energy prices and global end-market demand,” Mr Pang added.HKTDC Research will unveil its latest export forecast at a press conference on Monday, 29 June.HKTDC Media Room: https://mediaroom.hktdc.com/enMedia enquiriesPlease contact the HKTDC’s Communications & Public Affairs Department:Jane CheungTel: (852) 2584 4137Email: jane.mh.cheung@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
ICETECH and PARKEE, a CentrePark Group Subsidiary, Sign MOU to Establish Strategic Collaboration Framework for Indonesia’s Smart Parking Market ACN Newswire

ICETECH and PARKEE, a CentrePark Group Subsidiary, Sign MOU to Establish Strategic Collaboration Framework for Indonesia’s Smart Parking Market

JAKARTA, June 25, 2026 - (ACN Newswire via SeaPRwire.com) - Beijing ICETECH Science and Technology Co., Ltd. (“ICETECH”) and PT Inovasi Anak Indonesia (“PARKEE”), a subsidiary of CentrePark Group, signed a Memorandum of Understanding (“MOU”) on June 17, 2026, at Treasury Tower in South Jakarta. The MOU establishes a strategic collaboration framework to accelerate the digital transformation of Indonesia’s parking infrastructure, combining ICETECH’s proven AI vision and smart parking solutions with PARKEE’s extensive local operating network.The MOU was signed by Cui Kai, CEO of ICETECH, and Wilson Sumanang, CTO of PARKEE. CentrePark Group CEO Charles Richard Oentomo, CFO Chris Haryadi, and other representatives attended the signing.Under the MOU, ICETECH and PARKEE will collaborate on the deployment of smart parking technologies across Indonesia, focusing on intelligent hardware integration, digitalization of parking operations, and adaptation to local market requirements. The parties intend to jointly develop pilot projects that align technology deployment with local operating scenarios, and will evaluate potential business models for broader commercial rollout and long-term collaboration. Indonesia’s smart parking market is projected to grow at a compound annual rate of 16.45% through 2028, providing a strong backdrop for the collaboration.About ICETECHFounded in Beijing, ICETECH is a smart parking and urban mobility technology company with 14 years of experience and the leading market share in China’s static traffic sector. Its AI vision hardware and cloud-based platform serve more than 20,000 parking facilities and over 140 million registered vehicles, with products shipped to more than 80 countries and regions. ICETECH is recognized as a National “Little Giant” enterprise and counts Intel Capital among its strategic investors, and is expanding internationally across Southeast Asia, the Middle East, Europe, and Latin America.About PARKEE / CentrePark GroupPARKEE is the digital parking operating system and technology platform of CentrePark Group, one of Indonesia’s leading smart mobility and parking solution providers, managing more than 750 project sites across over 60 cities. Founded in Jakarta in 2009, the group’s ecosystem is now delivering beyond traditional parking operator services, including integrated parking solutions as well as value added services nationwide.Company: Beijing ICETECH Science and Technology Co., Ltd.Contact Person: YE LINEmail: rainie.ye@icetech-china.com Website: https://icetechglobal.com/ Telephone: +86 13714120690City: Beijing Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Everest Medicines and Hainan Herui have entered into a commercialization collaboration relating to Hainan Herui’s budesonide enteric capsules, further enhancing patient access to the medication ACN Newswire

Everest Medicines and Hainan Herui have entered into a commercialization collaboration relating to Hainan Herui’s budesonide enteric capsules, further enhancing patient access to the medication

HONG KONG, Jun 24, 2026 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK) announced that Everest Medicines and Hainan Herui have entered into a commercialization collaboration relating to Hainan Herui's budesonide enteric capsules, which were approved by the National Medical Products Administration (NMPA) in December 2025.Pursuant to this collaboration, Hainan Herui’s budesonide enteric capsules will be permitted to be launched in the Chinese mainland market, with Everest Medicines responsible for their commercialization. Everest Medicines will provide rigorous technical guidance and quality audits over Hainan Herui’s manufacturing and supply processes. This collaboration is expected to enhance patient access to the combined franchise of NEFECON(R) and Hainan Herui’s budesonide enteric capsules. This collaboration is subject to the satisfaction of customary closing conditions.As the world’s first approved etiological treatment for IgA nephropathy (IgAN), NEFECON(R) targets the Peyer’s patches in the terminal ileum to address the root cause of the disease, providing patients with an innovative therapeutic solution distinct from traditional supportive care.In recent years, with the continuous accumulation of global and Chinese real-world studies, the clinical value of NEFECON(R) across multiple critical dimensions, including etiological treatment, early intervention, long-term treatment, management across different chronic kidney disease (CKD) stages, and refractory IgAN, has been validated. At the 63rd European Renal Association (ERA) Congress, Everest Medicines presented 23 abstracts, including 21 real-world studies conducted in China. These findings further validate the efficacy and safety of NEFECON(R) in clinical practice, providing patients with more robust evidence-based support.Market data shows that China currently has approximately 5 million IgAN patients, with more than 120,000 new cases diagnosed annually. Furthermore, Chinese IgAN patients experience rapid disease progression and poor prognosis, representing a massive unmet clinical need. Against the backdrop of a large IgAN patient base and rising demand for long-term disease management, improving access to early etiological treatment and expanding the coverage of standardized treatment have become pivotal pathways to driving overall patient benefits. Accordingly, this commercialization collaboration between Everest Medicines and Hainan Herui leverages Everest Medicines’ established commercialization system and quality management capabilities. It will enhance the accessibility of relevant products in the Chinese market and is expected to further accelerate the clinical landing of standardized treatments, ultimately benefiting a broader population of IgAN patients. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
VivaTech 2026 Hong Kong Tech Pavilion connects local start-ups with European opportunities ACN Newswire

VivaTech 2026 Hong Kong Tech Pavilion connects local start-ups with European opportunities

HONG KONG, Jun 24, 2026 - (ACN Newswire via SeaPRwire.com) - Viva Technology (VivaTech) 2026, the annual technology and start-up extravaganza, successfully concluded in Paris, France last week. The Hong Kong Trade Development Council (HKTDC), together with strategic partner the Hong Kong Economic and Trade Office in Brussels (Brussels ETO), and supporting organisations including Hong Kong Science and Technology Parks Corporation (HKSTP), The Hong Kong Polytechnic University, Hong Kong Productivity Council (HKPC), The Hong Kong University of Science and Technology, and Cyberport, hosted the Hong Kong Tech Pavilion to showcase innovative solutions from 24 local innovation and technology (I&T) enterprises and institutions to global investors and industry players.During the exhibition, a series of thematic seminars, start-up pitching sessions and networking events were held to facilitate industry exchanges and business matching, helping local start-ups seize opportunities in the European market and deepen their international collaboration networks.HKTDC’s Chris Lo, Regional Director, Europe, Central Asia & Israel, stated: “VivaTech 2026's Hong Kong Tech Pavilion has achieved excellent results once again this year, facilitating multiple cross-border collaborations. We are pleased to see that some of these outcomes have gradually come to fruition from connections and exchanges initiated last year. Through its participation in overseas promotional platforms, the HKTDC has been helping local start-ups build networks and increase their exposure in international markets, creating collaboration opportunities for them and supporting their expansion into global markets, thereby injecting sustained momentum into Hong Kong's innovation and technology development."The participating start-ups and institutions included Formwork IO, which specialises in developing carbon-negative construction materials and sustainable solutions, which was selected as one of the top 30 finalists for VivaTech's "Tech for Change" Award. Tech for Change recognises start-ups that leverage innovative technology to drive positive impact for the environment, society or health, with an emphasis on the parallel pursuit of impact and commercial value. The finalists were selected from exhibiting start-ups worldwide based on their high growth potential. Additionally, from numerous startups and institutions worldwide, the organiser selected two Hong Kong Tech Pavilion I&T companies including PointFit Technology, a developer of wearable health monitoring and smart sports solutions, and Robocore Technology Limited, which develops globally leading open-platform service robot solutions, to give live demonstrations at VivaTech's Discovery Stage to buyers and investors around the world. These achievements fully demonstrate the innovative capabilities and international competitiveness of Hong Kong startups in health technology, artificial intelligence, and other fields.Forging cross-regional collaborations with fruitful resultsSeveral participating companies successfully established connections with European investors, large enterprises and industry partners, and commenced business discussions, laying the groundwork for subsequent cooperation. Among them, Robocare Technology is in negotiations with JCDecaux, a France-based multinational outdoor advertising company, for a cooperation agreement that will provide 1,000 robots to JCDecaux for marketing campaigns. Robocore Technology first connected with JCDecaux at the Hong Kong Tech Pavilion at VivaTech last year. Its CEO, Lim Long-hei, said: "Leveraging the business connections we have built through the Hong Kong Tech Pavilion at VivaTech over the past two years, we hope to further deepen our collaboration with European multinational corporations, achieve greater market share, and attain rapid business growth in Europe and beyond."Additionally, LeafIoT Technology Limited signed a Memorandum of Understanding with the Lecco Campus of Politecnico di Milano to further advance their cooperation and accelerate the pace of expanding into the European market. LeafIoT Technology specialises in developing smart tree monitoring solutions. The two parties will collaborate in talent cultivation and technological innovation, jointly promoting the application and market expansion of AI algorithms and remote sensing technology in enhanced tree monitoring and health assessment. LeafIoT Technology's innovative solutions have successfully attracted international partnership interest. Its Managing Director, Chan Pak-kwan, said: "We hope to extend Hong Kong's industry-university-research model further into Europe, while promoting the R&D achievements of Hong Kong institutions, and deepening collaboration with European academic institutions, thereby achieving five- to ten-fold business growth."During VivaTech, the HKTDC hosted a series of seminars, start-up pitching sessions, and networking events to facilitate in-depth exchanges between investors and start-ups. The Special Representative for Hong Kong Economic & Trade Affairs to the European Union, Shirley Yung, attended the thematic seminar and networking event titled "Building Resilient Tech Ecosystems: Powering the Next Wave of International Tech Leadership from Hong Kong" on 19 June. In Yung’s speech, she said Hong Kong's innovation ecosystem brings together four powerful advantages: top-tier research and talent, deep pools of global capital, unparalleled access to the Guangdong-Hong Kong-Macao Greater Bay Area innovation cluster, and strong connectivity to global markets, providing businesses with a comprehensive platform to innovate, scale up and expand into the Asian and global markets.The subsequent discussion session revolved around the strengths of Hong Kong's innovation and technology ecosystem, and how to leverage Hong Kong as a springboard to explore international markets. Chief Executive Officer, Terry Wong from HKSTP shared that Hong Kong, with familiar frameworks in regulations, research and development excellence, enables a common ground for Europe companies to explore the vast market opportunities in the East; while Chief Innovation Officer, Yonghai Du from HKPC pointed out that Hong Kong possesses significant advantages in research capabilities and attracting international investment, including technical support to ensure that enterprise products meet international testing standards, thereby helping businesses successfully go global and expand into international markets.The HKTDC is actively working with local enterprises to participate in major international technology exhibitions, assisting start-ups to expand into overseas markets and increase opportunities to connect with international investors and buyers. Following the Consumer Electronics Show (CES 2026) in Las Vegas, USA in January this year, the Mobile World Congress (MWC), and ‘4 Years From Now’ (4YFN) exhibition dedicated to tech start-ups held in Barcelona, Spain in March, the HKTDC once again organised the Hong Kong Tech Pavilion at VivaTech, providing a platform for start-ups to showcase their innovative achievements and connect with international funding.The 10th VivaTech attracted participants from over 165 countries and regions worldwide, with more than 15,000 global start-ups and 200,000 visitors, making it one of the most important events in the global technology ecosystem. Hong Kong Tech Pavilion at VivaTech is a flagship initiative under the "Economic and Trade Express" in Europe, Brussels ETO, HKTDC and InvestHK also jointly organised a series of other promotional and networking events to provide targeted support to the participating Hong Kong tech start-ups in exploring the local market, including pitching sessions, thematic seminars, and other networking activities.List of 24 Start-ups and institutions at the Hong Kong Tech Pavilion: CategoryCompany Name1. Sustainable & Climate TechnologyAlbacastor Technology Limited2. AIGreen Limited 3. Asgard Group Limited 4. Formwork IO5. Green Vigor Limited6. Laputa Eco-Construction Material Company Limited7. LeafIoT Technology Limited8. Plasticvore Chain Ltd 9. AI and Software Solutions Cogniser Infotech Ltd10. D-Engraver Limited11. Midas Analytics Limited 12. OxGen Holdings Limited13. Pantheon Lab Limited14. SagaDigits Limited15. Robotics and Microelectronics TechnologyAnlaseo Technology Limited16. Bacbudy Limited17. Cybercrystal Technology Co., Limited18. Harmony SkyTech Limited19. Oriental Materials Hong Kong Limited20. Robocore Technology Limited21. Health TechnologyEieling Technology Limited22. Hong Kong Bionic Beet Robotics Limited23. PointFit Technology Limited 24. UniversityThe Hong Kong Polytechnic UniversityPhoto download: https://bit.ly/3SXwgb424 Hong Kong innovation and technology enterprises and institutions shine at VivaTech 2026 Hong Kong Tech Pavilion, showcasing the city's scientific research prowess. LeafIoT Technology Limited and the Lecco Campus of Politecnico di Milano sign a Memorandum of Understanding; PointFit Technology gives live demonstrations at VivaTech's Discovery Stage.During VivaTech, the HKTDC organised a series of seminars, start-up pitching sessions and networking events to facilitate in-depth exchanges between investors and start-ups.Shirley Yung, Special Representative for Hong Kong Economic & Trade Affairs to the European Union, attended a thematic seminar and networking reception held on Friday (June 19) and delivered a keynote speech.Websites: https://vivatech.com/exhibitors/hktdc-hong-kong-trade-development-councilMedia enquiriesFor enquiries, please contact HKTDC’s Communications & Public Affairs Department:Winnie KanTel: (852) 2584 4055Email: winnie.wy.kan@hktdc.orgMedia Room: http://mediaroom.hktdc.comAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Airwheel Launches SE3SXD AI Cabin Suitcase, Introducing a New Era of Smart Luggage, Electric Suitcases and Intelligent Travel ACN Newswire

Airwheel Launches SE3SXD AI Cabin Suitcase, Introducing a New Era of Smart Luggage, Electric Suitcases and Intelligent Travel

BRUSSELS, BELGIUM, June 24, 2026 - (ACN Newswire via SeaPRwire.com) - Airwheel, a global innovator in smart mobility and intelligent travel solutions, today officially unveiled the SE3SXD Full-Intelligent AI Suitcase, a breakthrough product that combines the functionality of a smart suitcase, electric suitcase, riding suitcase, cabin suitcase, AI luggage, and smart luggage into a single intelligent travel platform.For more than a century, luggage has remained largely unchanged, serving primarily as a passive storage tool. The Airwheel SE3SXD smart luggage challenges that convention by transforming luggage into an intelligent travel companion capable of smart mobility, real-time connectivity, and AI-powered interaction.One-Key Evolution: From Cabin Suitcase to AI Travel CompanionPowered by Airwheel’s proprietary fourth-generation AI intelligent control system, the SE3SXD introduces an industry-leading dual-intelligence architecture that integrates a fully intelligent suitcase body with a fully connected smart control handle.With a single press, the AI suitcase automatically transforms from a standard cabin suitcase into a rideable power suitcase. The entire deployment process—including structural extension, system activation, and power adaptation—is completed automatically, eliminating the need for manual operation or smartphone control.The result is a truly intuitive travel experience where intelligent technology works naturally in the background.Redefining Mobility with Electric Suitcase TechnologyDesigned for airports, railway stations, convention centers, and urban mobility scenarios, the Airwheel SE3SXD scooter suitcase brings automotive-inspired intelligent drive technology to the smart luggage category.Key features include:AI adaptive power managementHigh-torque brushless motor systemIntelligent acceleration and brakingMultiple riding modesMaximum riding speed of 9.9 km/h (6.15 mph)Riding range up to 10 km (6.2 miles)Static load capacity up to 95 kg (209 lbs)Unlike conventional luggage that must be pulled or pushed, the rideable suitcase allows travelers to move efficiently through large transportation hubs while reducing fatigue.Smart Luggage Built for Global Air TravelDespite its advanced mobility capabilities, the SE3SXD rideabled luggage remains fully compliant with international carry-on requirements.The smart suitcase features:Standard 20-inch cabin suitcase dimensionsAirline-approved 73.26Wh removable batteryIATA-compliant battery systemOne-second battery removalLightweight body weighing only 6.8 kgThis design allows travelers to enjoy the convenience of an electric suitcase without sacrificing airline compatibility.AI Luggage with Apple Find My Global TrackingTo address growing concerns around lost baggage and travel security, Airwheel has integrated a comprehensive smart luggage protection ecosystem.Apple Find My IntegrationThe AI power luggage connects directly to Apple's Find My network, enabling global location tracking even when Bluetooth is disconnected or the suitcase is powered off.Users can also trigger sound alerts remotely, making it easier to locate luggage in airports, hotels, or crowded public spaces.Smart App ConnectivityThrough the Airwheel App, users can access:Battery monitoringSpeed managementRemote control functionsCruise controlAmbient lighting customizationSystem diagnosticsThe system can also provide instant alerts if the suitcase is moved unexpectedly.TSA-Approved SecurityA TSA-approved lock provides enhanced protection while maintaining compliance with international airport security requirements.Award-Winning Design Meets Smart Travel InnovationConstructed from aerospace-grade aluminum alloy and finished with a premium nano-textured surface, the SE3SXD smart suitcase combines durability with luxury aesthetics.Available in:Deep Space BlackLuxury SilverVibrant PinkThe smart suitcase incorporates Airwheel’s portfolio of more than 600 global patents and has received multiple international design awards for innovation and industrial design excellence.All intelligent systems are integrated within the suitcase structure, preserving practical storage space for 3–5 days of travel essentials.More Than Smart Luggage: A Portable Power SolutionThe airline-approved removable battery also functions as a portable power source.Integrated fast-charging ports allow travelers to charge smartphones, tablets, cameras, and other electronic devices while traveling.By combining the functions of a smart suitcase, electric suitcase, portable power bank, and personal mobility device, the SE3SXD offers a complete intelligent travel solution for modern consumers.Designed for Every JourneyWhether traveling for business, leisure, commuting, or gifting, the Airwheel SE3SXD delivers a smarter and more connected travel experience.From airport terminals to city streets, the AI suitcase transforms every journey into a seamless blend of mobility, convenience, and intelligent interaction.About AirwheelAirwheel is a global leader in smart mobility and intelligent travel technology, specializing in AI suitcases, smart luggage, electric suitcases, rideable suitcases, and cabin luggage solutions. Backed by over 600 international patents, award-winning industrial design, and a fully integrated R&D ecosystem, Airwheel continues to redefine the future of intelligent travel worldwide.Media ContactCompany: AirwheelContact: Media TeamWebsite: https://www.airwheel.net Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

China Risun Group (1907.HK) Strengthens Market Confidence Through Continued Share Repurchases and Management Shareholding Increases

HONG KONG, Jun 24, 2026 - (ACN Newswire via SeaPRwire.com) - China Risun Group Limited (1907.HK) today announced the repurchase of 2.567 million ordinary shares. Since the launch of its buyback program on June 18, the company has cumulatively repurchased 8.021 million shares. In addition, Mr. Yang Lu, Executive Director, Vice President, and General Manager of Cangzhou Risun, increased his personal holdings by 200,000 shares on June 22. These actions underscore the company’s and management’s strong confidence in Risun’s long-term growth prospects and commitment to safeguarding shareholder value.Repurchased shares are held as treasury stock, with total holdings now reaching 184 million shares. These shares may be allocated to employee equity incentive programs. Between September 2025 and January 2026, Risun granted 14.418 million shares to 797 mid- and senior-level employees, reinforcing a shared community of interests, careers, and destiny.Since its listing in 2019, China Risun Group, together with major shareholders, directors, and executives, has actively repurchased and increased holdings in the company. To date, the company has repurchased 237 million shares, major shareholders have added 66.84 million shares, and directors and executives have increased holdings by 7.779 million shares. Following shareholder authorization on May 29, 2026, the Board has been approved to repurchase up to 428 million shares, providing ample flexibility for future buybacks while maintaining public float.With resilient operations and steady business development, management remains confident in the company’s outlook. Despite external market pressures, Risun’s intrinsic value is not yet fully reflected in its market capitalization. Through share repurchases, management shareholding increases, and equity incentives, the company continues to align the interests of shareholders, employees, and the enterprise.Looking ahead, China Risun Group will accelerate strategic expansion into new energy and new materials, further enhancing its core competitiveness and driving sustainable growth. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Datavault AI Inc. (NASDAQ: DVLT) and WiSA Technologies Announce the Goho LS7 2.0 and 5.1 Home Theater Systems with WiSA E Wireless Connectivity ACN Newswire

Datavault AI Inc. (NASDAQ: DVLT) and WiSA Technologies Announce the Goho LS7 2.0 and 5.1 Home Theater Systems with WiSA E Wireless Connectivity

PHILADELPHIA, PA, June 23, 2026 - (ACN Newswire via SeaPRwire.com) - Datavault AI Inc. (NASDAQ:DVLT), through its Acoustic Sciences division's WiSA Technologies, today announced integration of the WiSA E Enterprise module in the new LS7 2.0 and 5.1 wireless home audio and karaoke systems from Goho, a brand of Goldhorn. These two stunning new systems are designed to bring high-definition two-channel and immersive 5.1 channel surround sound into the home entertainment environment with the simplicity and reliability of WiSA wireless audio transmission."Goldhorn has built a strong reputation for delivering premium audio components to the mobile audio market, and we are very excited to enter the home audio space with these two new systems designed to deliver the same premium experiences. WiSA technology is the perfect wireless solution to meet our requirements for robust connection, high-quality audio transmission, reliability, and simplicity for the end-user."- Chen Xiangzhen, Product Manager, Goldhorn Electronics Co., Ltd (Fujian)"Our scalable technology solutions solve for interoperability between devices that transmit secure, high-definition sound, enable spatial control, and - through both our semiconductor modules and WiSA E - which the Company believes are positioned to become the industry standard and quality leader in wireless multi-channel audio transmission."- Nathaniel Bradley, CEO, Datavault AI, Inc.The Goho LS7 systems are anchored by a 4K Ultra HD projector offering HDMI, optical, USB, and Ethernet connectivity. The 2.0 speaker system features two tall, thin, full-range speakers that can be hidden in any environment or showcased to show off their highly styled design. The 5.1 delivers immersive audio through five identical satellite speakers and a subwoofer, enveloping the listener with HD-quality audio from their favorite content. Both systems can also be the center of the party with their home karaoke capabilities and the included microphones."Goldhorn has demonstrated its premium audio capabilities for years in the car audio space, and we are very excited to be a part of their entry into the home audio entertainment world through the Goho brand. The two LS7 systems offer versatility and outstanding performance, making them great solutions for a wide range of use-cases within the home and beyond."- Tony Ostrom, President, WiSA® Association and VP Marketing, WiSA® TechnologiesThe Goldhorn LS7 systems are distributed in China and are available now.WiSA E technology offers module and software solutions for home entertainment systems and components of all types. Our wireless audio solutions are also positioned perfectly for integration into the emerging markets of robotics, holograms, drones, and other areas where multi-channel, high-definition, low-latency, and tightly synchronized wireless audio connectivity, distribution, and control are essential for great experiences.About Datavault AI Inc.Datavault AI™ (NASDAQ:DVLT) is leading the way in AI-driven data experiences, valuation, and monetization of assets in the Web 3.0 environment. The Company's cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Sciences and Data Sciences divisions.Datavault AI's Acoustic Sciences division features WiSA®, ADIO®, and Sumerian® patented technologies and industry-first foundational spatial and multichannel wireless, high-definition sound transmission technologies with intellectual property covering audio timing, synchronization, and multi-channel interference cancellation. The Data Science division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation, and secure monetization.Datavault AI's platform serves multiple industries, including high-performance computing software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy, and more. The Information Data Exchange® enables Digital Twins and the licensing of name, image, and likeness by securely attaching physical real-world objects to immutable metadata, fostering responsible AI with integrity. The Company's technology suite is fully customizable and offers AI- and machine-learning-based automation, third-party integration, detailed analytics and data, marketing automation, and advertising monitoring.The Company is headquartered in Philadelphia, PA. For more information, visit www.dvlt.ai. Investor information is available at dvlt.ai. Technology news and insights are published at dvlt.ai/insights.About the WiSA® AssociationThe WiSA Association is an independent industry organization managing the WiSA wireless audio standard, including WiSA E interoperability certification, membership, and the brand ecosystem. The Association's certification tools and governance infrastructure ensure that WiSA E products from any manufacturer work together without configuration. The WiSA Association's patented technology is licensed through Datavault AI Inc. (NASDAQ:DVLT). Tony Ostrom serves as President of the WiSA Association.About GoldhornGoldhorn Electronics Co., Ltd (Fujian) is an audio-video technology company with deep expertise in both optical and acoustic domains. The company has built a strong reputation in the mobile audio market and has also accumulated extensive research and development capabilities in display and imaging technologies, forming a unique technological approach that spans from optics to acoustics, from video to audio. Through its Goho brand, the company brings integrated, premium audio-video experiences into the home entertainment space, offering a range of home theater and karaoke systems designed to deliver exceptional picture quality, immersive sound, and user-friendly functionality.Forward-Looking StatementsThis press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and other applicable securities laws. Forward-looking statements are statements that are not historical facts and may be accompanied by words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "plan," "predict," "potential," "seem," "seek," "future," "outlook," "positioned," or variations of such words or expressions of similar meaning. These forward-looking statements include, but are not limited to: statements regarding the anticipated commercial success and consumer adoption of the Goho LS7 2.0 and 5.1 home theater and karaoke systems; the expected performance, reliability, and market reception of WiSA E wireless audio technology as integrated into Goldhorn's Goho product line; the Company's belief that WiSA E Enterprise module and semiconductor solutions have achieved and will maintain a position as an industry standard and quality leader in wireless audio transmission; statements regarding the scalability of WiSA E technology to solve cross-brand interoperability challenges on an enterprise scale; the anticipated expansion of WiSA E adoption among additional global premium acoustic brands; the expected distribution, availability, and sales performance of the Goldhorn LS7 systems in China and other potential markets; statements regarding the suitability and positioning of WiSA E technology for integration into emerging markets including robotics, holograms, drones, and other applications requiring multi-channel, high-definition, low-latency, and tightly synchronized wireless audio connectivity; and any other statements regarding the future business, operations, financial performance, or strategic direction of Datavault AI Inc. and its Acoustic Sciences division.These forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including, but not limited to: the risk that the Company will not achieve its anticipated revenue and commercial objectives for its Acoustic Sciences division; risks related to the Company's ability to deploy its technologies and gain or maintain market share in its target markets; the risk that market adoption of WiSA E technology by consumer electronics manufacturers, distributors, and end-users may not occur at the pace or scale anticipated; risks associated with international distribution partnerships, manufacturing relationships, geographic market conditions, and supply chain dependencies; the risk that Datavault AI will incorrectly anticipate market trends or fail to successfully exploit business opportunities in home entertainment, consumer electronics, and adjacent emerging technology sectors; risks related to the development, certification, and interoperability performance of WiSA E products across manufacturers; the risk that competing wireless audio technologies may achieve broader adoption or superior market positioning; changes in market demand for the Company's products and services; changes in economic, market, or regulatory conditions, including international trade regulations that may affect the Company's business with Goldhorn and other foreign partners; risks associated with technological development, integration, and interoperability certification processes managed through the WiSA Association; and other risks and uncertainties as more fully described from time to time in the Company's filings with the U.S. Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, copies of which are available at www.sec.gov and at ir.datavaultsite.com. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.Readers are cautioned not to place undue reliance on these and other forward-looking statements contained herein.Trademarks, Trade Names, Service Marks, and CopyrightsWe own or have rights to use various trademarks, trade names, service marks, and copyrights, which are protected under applicable intellectual property laws. This press release also contains trademarks, trade names, service marks, and copyrights of other companies, which are, to our knowledge, the property of their respective owners. Solely for convenience, certain trademarks, trade names, service marks and copyrights referred to in this press release may appear without the ©, ®, and ™ symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensors to these trademarks, trade names, service marks and copyrights. We do not intend our use or display of other parties' trademarks, trade names, service marks or copyrights to imply, and such use or display should not be construed to imply a relationship with, or endorsement or sponsorship of us by, these other parties.Media Contact:marketing@dvlt.aiInvestor Contact:Edward BargerVP, Investor Relationsebarger@dvlt.ai | ir@dvlt.aiSOURCE: Datavault AI Inc Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Jacobson Pharma Announces FY2026 Annual Results ACN Newswire

Jacobson Pharma Announces FY2026 Annual Results

KEY HIGHLIGHTS- Revenue held steady at HK$1,569.5 million- Profit attributable to equity shareholders increased to HK$301.6 million- Recommended final dividend of HK4.75 cents per share- Strong demand for chronic disease medicines underpinned core performance amid normalised seasonal respiratory demand.- Expanded specialty medicines portfolio through 46 in-licensing agreements; secured 23 new product approvals and expanded R&D pipeline to 241 products- Steady progress on the smart pharmaceutical manufacturing project at Tai Po InnoParkHONG KONG, Jun 23, 2026 - (ACN Newswire via SeaPRwire.com) - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines and specialty drugs, today announced the annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2026 ("FY2026" or the "Reporting Year").Despite the normalisation of seasonal healthcare demand following the prolonged influenza season in the prior year, Jacobson Pharma delivered resilient results in FY2026 with revenue remaining broadly stable at HK$1,569.5 million (FY2025: HK$1,576.9 million). Meanwhile, profit attributable to equity shareholders increased to HK$301.6 million from HK$300.8 million, primarily due to improved operational efficiency, disciplined cost management, and the growing contribution from specialty medicines, newly in-licensed products, and new product launches.The Group maintained a healthy financial position and stable operating cash flow generation during the Reporting Year, providing the flexibility to pursue strategic investments while supporting sustainable long-term growth.The Board recommends the payment of a final dividend of HK4.75 cents per share (FY2025: HK5.50 cents per share). Including the interim dividend of HK4.25 cents per share already paid, the total dividend for FY2026 would be HK9.00 cents per share.Strengthening Growth Drivers through Portfolio ExpansionThe Group's generic drugs business remained resilient during the Reporting Year, supported by continued growth in chronic disease therapies, while demand for seasonal cold and flu medicines moderated following the exceptionally prolonged influenza season in the prior year. Benefiting from structural healthcare trends, including Hong Kong's ageing population, the rising prevalence of chronic illnesses, and the increasing emphasis on preventive and primary healthcare, the Group recorded solid growth across its core therapeutic categories, led by cardiovascular, central nervous system, and oncology-related therapies.To drive future expansion, the Group continued to strengthen its product portfolio through targeted research and development efforts and strategic in-licensing initiatives. During the Reporting Year, it secured regulatory approvals for 23 new products and expanded its R&D pipeline to 241 products spanning a diverse and yet market-driven range of therapeutic areas.The Group further diversified and enhanced its specialty medicines portfolio via a proactive in-licensing strategy. It secured exclusive rights to 46 specialty medicines, biologics, vaccines, and advanced therapies across multiple high-potential fields, including oncology, haematology, immunology, cardiology, and neurology. These initiatives significantly bolster the Group’s product pipeline for sustainable, long-term growth.Translating Innovation into Patient AccessThe Group is committed to making meaningful strides in translating pharmaceutical innovation into tangible clinical impact.A case in point is the Group’s continued effort to support patient access to Axicabtagene Ciloleucel (Yikaida), a CAR-T cell therapy, in Hong Kong and Macau through its specialised Advanced Therapeutic Products logistics and patient care support platform. Patients in both markets have already received the therapy, underscoring the Group's role in facilitating access to advanced cancer treatments in the region.Investing in Manufacturing Excellence and Digital TransformationThe Group maintained steady progress to advance its smart pharmaceutical manufacturing project at Tai Po InnoPark under the Hong Kong Government's New Industrialisation Acceleration Scheme. During the Reporting Year, the Group finalised the appointment of the main contractor for the specialised infrastructure and design-and-build works, marking a significant milestone in the development of its advanced manufacturing facility.Upon completion, the facility will substantially enhance the Group's production capacity, technological capabilities, and operational efficiency, further strengthening its long-term manufacturing platform and supporting future growth.Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma, said: “FY2026 witnessed the resilience of our business model and the strength of our strategic foundations. Despite normalised seasonal healthcare demand, the Group delivered improved profitability while continuing to invest in key growth drivers.The expansion of our specialty medicines portfolio, good progress on advanced therapeutics initiatives, and the development of our smart manufacturing facility have further strengthened our foundations for sustainable growth.Looking ahead, favourable demographic trends, healthcare reforms, and rising demand for chronic disease management and specialty medicines continue to present attractive opportunities. With a robust pipeline, diversified specialty portfolio, focused investment in advanced manufacturing, and a dedicated team, we remain well-positioned to capture opportunities and deliver long-term value to stakeholders.”About Jacobson Pharma Corporation Limited (Stock Code: 2633)Jacobson Pharma is a leading pharmaceutical company in Hong Kong vertically integrated and engaged in the research, development, production, sale, and distribution of essential medicines and specialty drugs. As a major provider of generic drugs in Hong Kong, the Group has one of the most extensive sales and distribution coverage for both the private and public sectors in Hong Kong, with an expanding reach into strategically selected Asian markets.The Group is committed to strategically enhancing its portfolio through research and development, manufacturing excellence, and the introduction of high-value specialty products. With its headquarters in Hong Kong and operating subsidiaries across the region, the Group continues to strengthen its position as a trusted healthcare partner dedicated to improving patient access to quality medicines and innovative therapies. For more details about Jacobson Pharma, please visit the Group's website: http://www.jacobsonpharma.comFor media inquiries, please contact:Strategic Financial Relations LimitedVicky LeeTel: (852) 2864 4834Email: vicky.lee@sprg.com.hkRachel KoTel: (852) 2114 2370Email: rachel.ko@sprg.com.hk Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More